Jacobs Levy Equity Management, Inc Pmv Pharmaceuticals, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $25.8 Billion
- Q4 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 539,893 shares of PMVP stock, worth $761,249. This represents 0.0% of its overall portfolio holdings.
Number of Shares
539,893
Previous 705,593
23.48%
Holding current value
$761,249
Previous $1.05 Million
22.45%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PMVP
# of Institutions
78Shares Held
41.8MCall Options Held
500Put Options Held
500-
Orbimed Advisors LLC San Diego, CA6.48MShares$9.13 Million0.26% of portfolio
-
Sio Capital Management, LLC New York, NY3.57MShares$5.04 Million2.01% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.51MShares$4.95 Million0.08% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.47MShares$4.89 Million3.25% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.7 Million0.54% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $64.3M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...